The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

The FDA has issued a classification for an existing mustard recall for Keith Valley and Red Boy Mustard after the products tested positive for salmonella.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Officials with the U.S. Food and Drug Administration have officially escalated a chocolate recall initially issued in ...

A chocolate recall was recently upgraded to warn consumers of a potential to “cause serious adverse health consequences of death.” ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Susan Krause of Rosemount alleges New Jersey-based Integra LifeSciences pressured her to lie to regulators. Integra says ...

An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...